Staphylococcus epidermidis on Skin: Role & Function

What is Staphylococcus epidermidis?

Staphylococcus epidermidis (S. epidermidis) is a gram-positive bacterium that permanently colonizes human skin from infancy onward. Unlike its pathogenic relative Staphylococcus aureus, S. epidermidis is generally commensal—meaning it lives on the skin without causing harm under normal conditions. Culture-independent sequencing studies, including the NIH Human Microbiome Project, have confirmed it as a dominant member of the skin microbiome across diverse body sites.

S. epidermidis thrives in sebaceous (oily) and moist environments, often making up 60–90% of the staphylococcal population on healthy skin. Its abundance is highest in the axillae (armpits), antecubital fossae (inner elbows), and inguinal folds. The bacterium forms part of the skin's "core microbiome"—the set of microbes found reliably across most healthy individuals.

How does S. epidermidis protect the skin?

S. epidermidis actively defends skin through chemical warfare against pathogens. Research from the Gallo laboratory at UC San Diego demonstrated that certain strains produce antimicrobial peptides, including a molecule called ESP (epidermin-like serine protease inhibitor), that selectively kill S. aureus but spare other commensal bacteria. This targeted inhibition helps maintain microbial balance without scorching the entire ecosystem.

Some S. epidermidis strains also produce phenol-soluble modulins (PSMs), small peptides that can modulate immune responses and biofilm formation. Work by Nakatsuji et al. (2017) showed that specific antimicrobial-producing strains of S. epidermidis are less abundant on the skin of patients with atopic dermatitis, who often experience S. aureus overgrowth. Transplantation of protective S. epidermidis strains reduced S. aureus colonization in both mouse models and human subjects.

S. epidermidis also appears to educate the skin immune system. Studies suggest the bacterium can stimulate keratinocytes to produce antimicrobial peptides like human β-defensin-2, priming the skin's innate defenses. This cross-talk between microbe and host represents a form of immune training that begins in early life.

Are all S. epidermidis strains beneficial?

Not all S. epidermidis is created equal—strain-level differences determine whether it acts as protector or opportunist. Whole-genome sequencing has revealed enormous genetic diversity within the species, with some strains carrying antimicrobial biosynthesis clusters and others lacking them entirely. The protective benefits documented in research depend on specific strains, not the species as a whole.

In immunocompromised individuals or when the skin barrier is breached, S. epidermidis can behave opportunistically. It is a leading cause of infections associated with indwelling medical devices like catheters and prosthetic joints, where it forms antibiotic-resistant biofilms. This dual nature—commensal on intact skin, pathogen in the wrong context—illustrates the importance of barrier integrity and immune competence.

Antibiotic resistance is increasingly common in S. epidermidis populations, likely due to selective pressure from medical and personal care product exposures. Methicillin-resistant S. epidermidis (MRSE) is now prevalent on human skin, though it rarely causes disease in healthy hosts. The reservoir of resistance genes in skin commensals may, however, transfer to more virulent species through horizontal gene transfer.

What disrupts S. epidermidis on skin?

Aggressive or frequent cleansing can temporarily reduce S. epidermidis abundance, though populations typically recover within hours to days. Studies on the impact of antimicrobial soaps and hand sanitizers show short-term depletion of skin bacteria, including staphylococci, followed by recolonization from deeper skin layers and environmental re-exposure. Chronic disruption, however, may shift community composition in ways that favor less beneficial strains or species.

Topical and systemic antibiotics profoundly alter S. epidermidis populations and select for resistant strains. Research on acne patients treated with long-term topical clindamycin or erythromycin shows widespread antibiotic resistance in their skin staphylococci. This collateral damage to the microbiome may reduce colonization resistance, potentially explaining why some individuals become more susceptible to skin infections after antibiotic courses.

Environmental factors also shape S. epidermidis communities. Occlusion (covering skin with bandages or tight clothing) increases moisture and can shift microbial composition. UV exposure, pH changes from skincare products, and seasonal humidity variations all influence staphylococcal density and strain distribution.

How does S. epidermidis interact with other skin microbes?

S. epidermidis exists within a complex microbial network, competing and cooperating with neighbors. It coexists with Cutibacterium acnes (formerly Propionibacterium acnes) in sebaceous areas, though the two occupy slightly different microenvironments—C. acnes dominating within follicles while S. epidermidis colonizes the skin surface. Cross-feeding and metabolic exchange likely occur, though specific interactions remain incompletely characterized.

The relationship between S. epidermidis and S. aureus is particularly well-studied due to clinical relevance. Beyond direct antimicrobial production, S. epidermidis may occupy binding sites and consume nutrients that S. aureus needs, a phenomenon called competitive exclusion. Individuals with diverse S. epidermidis strain populations appear more resistant to S. aureus colonization, suggesting that within-species diversity enhances colonization resistance.

Fungi like Malassezia species also share skin real estate with S. epidermidis, though little is known about their direct interactions. Given that both are lipophilic (lipid-loving) organisms, they may compete for sebum-derived nutrients in sebaceous regions.

The bottom line

Staphylococcus epidermidis is a cornerstone resident of healthy skin that provides protection against pathogens through antimicrobial production and immune modulation, but these benefits depend on having the right strains in the right context. Preserving diverse, healthy S. epidermidis populations—rather than depleting them through overzealous hygiene or antibiotics—may support skin barrier defense and microbial balance.